Skip to Content
 
Center for International Blood and Marrow Transplant Research

1702-01

Main Content

To report long term out-comes of patients with locally advance high risk triple negative breast cancer treated with adjuvant high dose chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

Study #: 1702-01

Study Status: Published

Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy.

Citation

Mohan M, Janz S, Brazauskas R, Dwinell MB, Teng BQ, Yun G, Dong J, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, D'Souza A.

Bone Marrow Transplantation. 2023, Aug 01: 58(8): 58(8):953-955. doi: 10.1038/s41409-023-02004-5. Epub 2023, May 06. PMCID:PMC10555486.

PubMed

PMID: 37149674

Abstract